BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 24875097)

  • 1. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.
    El-Jamal N; Erdual E; Neunlist M; Koriche D; Dubuquoy C; Maggiotto F; Chevalier J; Berrebi D; Dubuquoy L; Boulanger E; Cortot A; Desreumaux P
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G274-85. PubMed ID: 24875097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
    Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
    Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer.
    Trivedi S; Wiber SC; El-Zimaity HM; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G840-9. PubMed ID: 22323126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.
    Sigalet DL; Wallace LE; Holst JJ; Martin GR; Kaji T; Tanaka H; Sharkey KA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G211-21. PubMed ID: 17395898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
    Koehler JA; Harper W; Barnard M; Yusta B; Drucker DJ
    Cancer Res; 2008 Oct; 68(19):7897-904. PubMed ID: 18829546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
    Yusta B; Holland D; Waschek JA; Drucker DJ
    Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of metallothioneins as danger signals in the pathogenesis of colitis.
    Devisscher L; Hindryckx P; Lynes MA; Waeytens A; Cuvelier C; De Vos F; Vanhove C; Vos MD; Laukens D
    J Pathol; 2014 May; 233(1):89-100. PubMed ID: 24452846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled receptor 40 activation ameliorates dextran sulfate sodium-induced colitis in mice via the upregulation of glucagon-likepeptide-2.
    Kato S; Utsumi D; Matsumoto K
    J Pharmacol Sci; 2019 Jun; 140(2):144-152. PubMed ID: 31242961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
    Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
    Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adiponectin on murine colitis induced by dextran sulfate sodium.
    Nishihara T; Matsuda M; Araki H; Oshima K; Kihara S; Funahashi T; Shimomura I
    Gastroenterology; 2006 Sep; 131(3):853-61. PubMed ID: 16952554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.
    McDonagh SC; Lee J; Izzo A; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
    Zeng Z; Zhan L; Liao H; Chen L; Lv X
    Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis.
    Qi KK; Wu J; Wan J; Men XM; Xu ZW
    Peptides; 2014 Feb; 52():11-8. PubMed ID: 24274971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
    Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
    Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
    Terc J; Hansen A; Alston L; Hirota SA
    Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis.
    L'Heureux MC; Brubaker PL
    J Pharmacol Exp Ther; 2003 Jul; 306(1):347-54. PubMed ID: 12815012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.